SNY vs. GILD

In the year-to-date period, SNY achieves a 7.48% return, which is significantly lower than GILD's 16.11% return. Over the past 10 years, SNY has underperformed GILD with an annualized return of 3.57%, while GILD has yielded a comparatively higher 4.02% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SNY Sharpe Ratio is 0.46, which is lower than the GILD Sharpe Ratio of 2.45. The chart below compares the historical Sharpe Ratios of SNY and GILD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

SNY's dividend yield for the trailing twelve months is around 3.93%, more than GILD's 2.91% yield.

The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum GILD drawdown of -70.82%. Use the drawdown chart below to compare losses from any high point for SNY and GILD. For additional features, visit the drawdowns tool.

Sanofi (SNY) and Gilead Sciences, Inc. (GILD) have volatilities of 9.38% and 9.13%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Sanofi and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.